Target intelligence / Profile preview

Reactive oxygen species and nitric oxide (ROS/NO)

Target
ROS/NO
Molecular classification
Reactive molecules, Free radicals, Signaling molecules, Oxidants
01

Overview

Reactive oxygen species (ROS) and nitric oxide (NO) are a group of highly reactive, oxygen- and nitrogen-containing molecules that serve as critical regulators of cellular physiology [Sies et al., 2017]. In healthy tissues, they function as secondary messengers in signal transduction pathways, regulating processes such as vasodilation, immune response, and gene expression [StatPearls, 2023]. However, an imbalance between their production and the body's antioxidant defenses leads to oxidative and nitrosative stress, which causes damage to DNA, proteins, and lipids [Pizzino et al., 2017]. This damage is a hallmark of various pathologies, including cardiovascular diseases, neurodegeneration, and cancer. Therapeutic strategies involve the use of antioxidants and scavengers to neutralize excess ROS/NO or the use of donors to restore signaling in conditions like endothelial dysfunction [PubChem]. Because these molecules are ubiquitous and essential for normal function, pharmacological intervention requires precise targeting to avoid disrupting homeostatic signaling.

Other names
Reactive oxygen and nitrogen speciesRONSOxidantsFree radicalsReactive oxygen intermediates
02

Mechanism of action

Drugs targeting these species typically act as scavengers to neutralize reactive intermediates, as donors to supplement levels (e.g., NO donors), or as inhibitors of the enzymes responsible for their production (e.g., NADPH oxidase or Nitric oxide synthase inhibitors) [Pizzino et al., 2017].

03

Biological functions

Signal transductionImmune responseVasodilationApoptosisRedox homeostasisCell proliferation
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseDiabetesAging
05

Safety considerations

Interference with essential physiological signalingPotential for pro-oxidant effects at high dosesReductive stressNon-specific systemic effectsToxicity of metabolic byproducts
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)3-NitrotyrosineF2-isoprostanesGlutathione (GSH/GSSG) ratio

Beyond the preview

Go deeper on Reactive oxygen species and nitric oxide (ROS/NO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and nitric oxide (ROS/NO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call